suMMARY Twenty-five patients with 29 episodes of active systemic lupus erythematosus with central nervous system involvement were studied according to a uniform protocol. Brain scans were found to be abnormal in all patients studied, and electroencephalograms were abnormal in 20/25 patients. Serial brain scanning was found to be useful in the diagnosis of exacerbations and the monitoring of corticosteroid dosage.
In a recent study of 110 patients with systemic lupus erythematosus (SLE), we found major neuropsychiatric manifestations in 44 patients (40%) including severe psychiatic disturbances or localised neurological lesions (Lee et al., 1977) . The reported frequency of such manifestations in SLE ranges from 14-75% (Bennahum and Messner, 1975; Feinglass et al., 1976) , the incidence varying with the criteria used for inclusion.
In many instances, minor neuropsychiatric disturbances or severe headaches without localising signs are excluded because of poor neuropsychiatric and neuropathological correlations (Johnson and Richardson, 1968 ); yet these might represent active SLE with central nervous system (CNS) (Fig. 1) . The following 3 patterns were identified on anterior-posterior views: (a) a generalised peripheral rim widening (Fig. 2) , (b) a blurring and thickening of the peripheral rim of radionuclide uptake with inward extension of parasagittal activity producing the 'draped curtain' pattern ( Fig. 3) , and (c) a localised pattern of increased activity on the anterior view indicating increased activity in the fronto-parasagittal area (Harvey et al., 1954; Estes and Christian, 1971; Dubois, 1974; Sergent et al., 1975; Feinglass et al., 1976) of patients with CNS SLE, failed to emphasise the importance of intractable headache as a feature of CNS involvement. In our series, 21 patients had intractable headache as an important presenting feature, Six of these patients had intractable headache as the sole presenting feature of their CNS lupus.
Although CNS involvement in patients with SLE has been associated with more severe diseases as evidenced by clinical and/or serological activity (Bennahum and Messner, 1975; Gibson and Myers, 1976 ; Lee et al., 1977) , serological parameters have been poor indicators of CNS involvement. Depressed serum complement and elevated DNA-antibodies may occur in patients with CNS SLE, but are not as consistent as in lupus nephritis, to be useful for diagnosis. As seen in Table 2 , elevated DNAantibodies were detected in only 18 of 29 episodes and depressed CH50 or C3 complement levels were detected during 22 episodes of CNS lupus. CSF findings of increased DNA-antibodies, DNA-anti-DNA complexes, reduced levels of C3 and IgG again are not consistent markers of active CNS disease (Petz et al., 1971; Levin et al., 1972; Hadler et al., 1973; Lindstrom and Sjoholm, 1975; Small et al., 1977) .
The EEG was abnormal in 80% of our cases, but 5/25 or 20% with active CNS involvement showed no abnormality. This finding is in agreement with that of both Feinglass et al. (1976) where 71 % of those patients with CNS lupus had abnormal EEG findings, and Gibson and Myers (1976) who demonstrated abnormal EEG in 84% of patients with CNS SLE.
All of our patients with active CNS lupus had abnormal brain scans at the time of diagnosis of their disease. This is in agreement with Bennahum et al. (1974) who reported abnormal brain scans in 11/12 scans in 6 patients with active CNS lupus. It is, however, in marked contrast to other published reports. Feinglass et al. (1976) found only 2/26 brain scans to be abnormal among 26 neuropsychiatric episodes, despite the fact that 20 of 24 patients with normal scans had focal neurological signs and/or seizures.
Only 4 of the patients studied by Gibson and Myers (1976) had abnormal brain scans. However, they did not state how the scans were performed and how many of their patients had scans. Small et al. (1977) detected only 2 abnormal static brain scans of 10 scans performed on patients with CNS SLE. Fifty per cent of flow studies performed on these patients were abnormal. Again the scanning method was not reported. The discrepancy between these reports and our results may in part be due to the different technique used in brain scanning. We used the gamma camera to record the brain scans whereas Feinglass et al. (1976) and perhaps the others (Gibson and Myers, 1976; Small et al., 1977) Twenty-seven episodes of CNS lupus responded to therapy, 2 did not. Those patients in whom the brain scan abnormalities persisted or worsened were those who had a protracted clinical course of CNS lupus. They also required a higher dose of corticosteroid for a prolonged period of time for control of their CNS lupus. Two patients died with active CNS SLE despite high daily dose of corticosteroid (prednisone 100 mg). Neuropathological examination in one was normal and in the second revealed a sterile leptomeningitis with evidence of cerebral atrophy and positive immunofluorescent staining for IgM in the choroid plexus. This finding may support the hypothesis that the pathogenesis of CNS lupus may be secondary to an immune complex disease (Atkins et al., 1972) . 
